The University of Chicago Medicine announced on Thursday the completion of the construction phase of the AbbVie Foundation Cancer Pavilion.

Scheduled to open in April 2027 on UChicago Medicine's main campus in Hyde Park on the South Side, the 575,000-square-foot facility is the state's first and only of its kind dedicated to cancer.

Construction is supported in part by a USD75m donation from the AbbVie Foundation, a nonprofit dedicated to addressing health inequities and accelerating innovative solutions in underserved communities.

The AbbVie Foundation Cancer Pavilion aims to advance the future of cancer medicine while expanding access for patients and the community. The seven-storey facility brings together cancer specialists, advanced diagnostics, treatment, clinical trials, navigation, supportive services and survivorship care in one dedicated environment designed around patients and families.

Once fully operational, the pavilion is expected to serve approximately 200,000 outpatient visits and 5,000 inpatient admissions annually, with 80 private inpatient beds.

With construction complete, UChicago Medicine will enter the final phase preparing the building to welcome patients, including outfitting clinical spaces, testing systems and workflows, and training teams to operate in the new environment.